Stories » Treatment for Potential Exposure to Meningitis
Treatment for Potential Exposure to Meningitis
submitted by WLangley on Friday, October 29 2004 at 1:19 AM
On Friday, October 22, a party occurred on 611 Chamberlain Road which was attended by a UNC-CH student named Jonathan Davis. This student has since been diagnosed with meningococcal meningitis, which is better known as the bacterial form of meningitis. If you attended this party after 10:00 PM or have had face-to-face contact with Davis within the last 10 days, please visit the NCSU Student Health Center, at 2815 Cates Avenue, to receive preventative treatment, free of charge, consisting of a single dose of the Cipro antibiotic. If you have already received the meningococcal meningitis vaccine and believe you've been exposed, you should still visit the Student Health Center, as the vaccine cannot cover all bacteria that could cause meningitis.
If you think that you have been exposed, please visit the Student Health Center at one of these times:
Friday, October 29: from 8:00AM until 9:00PM Saturday, October 30: from 8:30AM until 11:30AM
^^ I completely understand where you are coming from, however I think it was a decision they made just to be on the safe side and be upfront as possible with everyone. They just wanted to attack the problem before it possibly turned into a bigger problem, but I do understand what you are saying.
YES it is common to release a name so that the public can come forward if they have been in contact with him... this could easily turn into a life or death situation if the people who were in contact with him don't receive care immediately
I was at that party, and that party was so packed it took me 5 minutes to walk through the living room. It sucks for the girls who live in that house. That's what you get for sharing shot glasses and marijuana blunts.
A medical perspective on meningococcal meningitis,
an acute infectious disease of children and young adults, caused by Neisseria meningitidis characterized by fever, headache, photophobia, vomiting, nuchal rigidity, seizures, coma, and a purpuric eruption; even in the absence of meningitis, meningococcemia can induce toxic phenomena such as vasculitis, disseminated intravascular coagulation, shock, and Waterhouse-Friderichsen syndrome due to adrenal hemorrhage; late complications include paralysis, mental retardation, and gangrene of extremities. Syn: cerebrospinal fever, epidemic cerebrospinal meningitis.
Approximately 2500 cases of invasive meningococcal disease occur annually in the U.S., with a case fatality rate of 10–15%. The incidence of endemic meningococcal disease peaks between late winter and early spring. Attack rates and case fatality rates are highest among children aged 6–12 months. Household exposure to tobacco smoke is a risk factor for meningococcal disease in children. Organisms are spread from person to person by direct contact and in saliva and respiratory secretions. The epidemiology of meningococcal disease is poorly understood. The nasopharyngeal carriage rate in the general population is 5–10%. This asymptomatic carrier state can persist for months or years and may confer protection against invasive disease. During epidemics of meningococcal meningitis, the carrier rate can approach 95%, yet fewer than 1% may develop the disease. Diagnosis is established by the finding of meningococci in cerebrospinal fluid or blood. Because meningococcemia can progress fulminantly to an irreversible stage, intravenous penicillin G, ampicillin, or chloramphenicol is begun as soon as the diagnosis is suspected, usually before laboratory confirmation. Intensive support of vital functions is crucial during the acute phase. Close contacts of known cases are treated prophylactically with rifampin or ciprofloxacin; mass prophylaxis may be appropriate in a confirmed institutional outbreak. A quadrivalent vaccine has been effective in preventing meningococcal disease due to serogroups A, C, W-135, and Y. Shortcomings of the vaccine are that it does not protect against serogroup B, which causes 30–40% of meningococcal disease in the U.S.; does not interrupt the carrier state; does not induce immunity quickly enough to protect a person already infected; and protects for only 4–5 years. Routine immunization is recommended only for military recruits, travelers to endemic areas, and others known to be at long-term high risk. A major objection to infant vaccination has been the poor induction of immunity in this age group to serogroup C, which causes 45% of meningitis in the U.S. Use of a meningococcal C vaccine conjugated to protein has yielded high initial titers of anticapsular and bactericidal antibody in infants and toddlers, as well as more prolonged protection and better response to booster doses.
"that guy's name should not have been posted openly on the internet like that, you have completely breeched his right to privacy!!!!!!!!!!!!"
his parents consented... hes my real good friend, his parents were of the thought that releasing his name may help people see if they need treatment. they dont want this to happen to any one else
but hes been talking and breathing on his own since thursday night and he recognized all of us who visited
his rash didnt look like that it was like splotches that were about the color of like a blood blister... essentially they are blood clots in the capilaries...